HOBOKEN, New Jersey, March 9 -- The American Journal of Hematology, a journal that says it provides coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease, published research articles on the following topics in its January 2024 edition (Vol. 99, Issue 1):

EDITORIAL PERSPECTIVES:

* Real-world evidence confirms thrombopoietin receptor agonists are safe and effective for all stages of immune thrombocytopenia
. . .

Click here for more information about our products